Colonization and infection of the human host by staphylococci: Adhesion, survival and immune evasion

Veterinary Dermatology

Volumn 20, Issue 5-6, 2009, Pages 456-470

  Foster, Timothy J ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIUM ADHERENCE; HETEROZYGOTE; HUMAN; IMMUNOLOGY; MICROBIOLOGY; NOSE; PHYSIOLOGY; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

BACTERIAL ADHESION; CARRIER STATE; HUMANS; NOSE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

BACTERIA (MICROORGANISMS); CANIS FAMILIARIS; RODENTIA; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS PSEUDINTERMEDIUS;

EID: 73149097879     PISSN: 09594493     EISSN: 13653164     Source Type: Journal    
DOI: 10.1111/j.1365-3164.2009.00825.x     Document Type: Article

References (149)

1. Bannoehr J, Ben Zakour NL, Waller AS et al. Population genetic structure of the Staphylococcus intermedius group: insights into agr diversification and the emergence of methicillin-resistant strains. Journal of Bacteriology 2007 189 : 8685 8692.
2. Peacock SJ, de Silva I, Lowy FD. What determines nasal carriage of Staphylococcus aureus? Trends in Microbiology 2001 9 : 605 610.
3. Massey RC, Horsburgh MJ, Lina G et al. The evolution and maintenance of virulence in Staphylococcus aureus: a role for host-to-host transmission? Nature Reviews Microbiology 2006 4 : 953 958.
4. Ni Eidhin D, Perkins S, Francois P et al. Clumping factor B (ClfB), a new surface-located fibrinogen-binding adhesin of Staphylococcus aureus. Molecular Microbiology 1998 30 : 245 257.
5. Perkins S, Walsh EJ, Deivanayaam CC et al. Structural organization of the fibrinogen-binding region of the clumping factor B MSCRAMM of Staphylococcus aureus. Journal of Biological Chemistry 2001 276 : 44721 44728.
6. Walsh EJ, O'Brien LM, Liang X et al. Clumping factor B, a fibrinogen-binding MSCRAMM (microbial surface components recognizing adhesive matrix molecules) adhesin of Staphylococcus aureus, also binds to the tail region of type I cytokeratin 10. Journal of Biological Chemistry 2004 279 : 50691 50699.
7. O'Brien LM, Walsh EJ, Massey RC et al. Staphylococcus aureus clumping factor B (ClfB) promotes adherence to human type I cytokeratin 10: implications for nasal colonization. Cellular Microbiology 2002 4 : 759 770.
8. Clarke SR, Wiltshire MD, Foster SJ. IsdA of Staphylococcus aureus is a broad spectrum, iron-regulated adhesin. Molecular Microbiology 2004 51 : 1509 1519.
9. Skaar EP, Schneewind O. Iron-regulated surface determinants (Isd) of Staphylococcus aureus: stealing iron from heme. Microbes and Infection 2004 6 : 390 397.
10. Clarke SR, Mohamed R, Bian L et al. The Staphylococcus aureus surface protein IsdA mediates resistance to innate defenses of human skin. Cell Host and Microbe 2007 1 : 1 14.
11. Clarke SR, Foster SJ. IsdA protects Staphylococcus aureus against the bactericidal protease activity of apolactoferrin. Infection and Immunity 2008 76 : 1518 1526.
12. Clarke SR, Brummell KJ, Horsburgh MJ et al. Identification of in vivo-expressed antigens of Staphylococcus aureus and their use in vaccinations for protection against nasal carriage. Journal of Infectious Diseases 2006 193 : 1098 1108.
13. Corrigan RM, Miajlovic H, Foster TJ. Surface proteins that promote adherence of Staphylococcus aureus to human desquamated nasal epithelial cells. BMC Microbiology 2009 9 : 22.
14. Corrigan RM, Rigby D, Handley P et al. The role of Staphylococcus aureus surface protein SasG in adherence and biofilm formation. Microbiology 2007 153 : 2435 2446.
15. Corrigan RM, Foster TJ. An improved tetracycline-inducible expression vector for Staphylococcus aureus. Plasmid 2009 61 : 126 129.
16. Schaffer AC, Solinga RM, Cocchiaro J et al. Immunization with Staphylococcus aureus clumping factor B, a major determinant in nasal carriage, reduces nasal colonization in a murine model. Infection and Immunity 2006 74 : 2145 2153.
17. van Belkum A, Emonts M, Wertheim H et al. The role of human innate immune factors in nasal colonization by Staphylococcus aureus. Microbes and Infection 2007 9 : 1471 1477.
18. Geoghegan JA, Smith EJ, Speziale P et al. Staphylococcus pseudintermedius expresses surface proteins that closely resemble those from Staphylococcus aureus. Veterinary Microbiology 2009 doi:.
19. van den Akker EL, Nouwen JL, Melles DC et al. Staphylococcus aureus nasal carriage is associated with glucocorticoid receptor gene polymorphisms. Journal of Infectious Diseases 2006 194 : 814 818.
20. Emonts M, de Jongh CE, Houwing-Duistermaat JJ et al. Association between nasal carriage of Staphylococcus aureus and the human complement cascade activator serine protease C1 inhibitor (C1INH) valine vs. methionine polymorphism at amino acid position 480. FEMS Immunology and Medical Microbiology 2007 50 : 330 332.
21. Emonts M, Uitterlinden AG, Nouwen JL et al. Host polymorphisms in interleukin 4, complement factor H, and C-reactive protein associated with nasal carriage of Staphylococcus aureus and occurrence of boils. Journal of Infectious Diseases 2008 197 : 1244 1253.
22. Graille M, Stura EA, Corper AL et al. Crystal structure of a Staphylococcus aureus protein A domain complexed with the Fab fragment of a human IgM antibody: structural basis for recognition of B-cell receptors and superantigen activity. Proceedings of the National Academy of Sciences of the USA 2000 97 : 5399 5404.
23. Diep BA, Gill SR, Chang RF et al. Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus. Lancet 2006 367 : 731 739.
24. Diep BA, Stone GG, Basuino L et al. The arginine catabolic mobile element and staphylococcal chromosomal cassette mec linkage: convergence of virulence and resistance in the USA300 clone of methicillin-resistant Staphylococcus aureus. Journal of Infectious Diseases 2008 197 : 1523 1530.
25. Gasque P. Complement: a unique innate immune sensor for danger signals. Molecular Immunology 2004 41 : 1089 1098.
26. Walport MJ. Complement. Second of two parts. New England Journal of Medicine 2001 344 : 1140 1144.
27. Walport MJ. Complement. First of two parts. New England Journal of Medicine 2001 344 : 1058 1066.
28. Durr MC, Kristian SA, Otto M et al. Neutrophil chemotaxis by pathogen-associated molecular patterns - formylated peptides are crucial but not the sole neutrophil attractants produced by Staphylococcus aureus. Cellular Microbiology 2006 8 : 207 217.
29. Ley K. Integration of inflammatory signals by rolling neutrophils. Immunology Reviews 2002 186 : 8 18.
30. Williams RJ, Ward JM, Henderson B et al. Identification of a novel gene cluster encoding staphylococcal exotoxin-like proteins: characterization of the prototypic gene and its protein product, SET1. Infection and Immunity 2000 68 : 4407 4415.
31. Fitzgerald JR, Reid SD, Ruotsalainen E et al. Genome diversification in Staphylococcus aureus: molecular evolution of a highly variable chromosomal region encoding the Staphylococcal exotoxin-like family of proteins. Infection and Immunity 2003 71 : 2827 2838.
32. Arcus VL, Langley R, Proft T et al. The Three-dimensional structure of a superantigen-like protein, SET3, from a pathogenicity island of the Staphylococcus aureus genome. Journal of Biological Chemistry 2002 277 : 32274 32281.
33. Bestebroer J, Poppelier MJ, Ulfman LH et al. Staphylococcal superantigen-like 5 binds PSGL-1 and inhibits P-selectin-mediated neutrophil rolling. Blood 2007 109 : 2936 2943.
34. Baker HM, Basu I, Chung MC et al. Crystal structures of the staphylococcal toxin SSL5 in complex with sialyl Lewis X reveal a conserved binding site that shares common features with viral and bacterial sialic acid binding proteins. Journal of Molecular Biology 2007 374 : 1298 1308.
35. Chung MC, Wines BD, Baker H et al. The crystal structure of staphylococcal superantigen-like protein 11 in complex with sialyl Lewis X reveals the mechanism for cell binding and immune inhibition. Molecular Microbiology 2007 66 : 1342 1355.
36. Chavakis T, Hussain M, Kanse SM et al. Staphylococcus aureus extracellular adherence protein serves as anti-inflammatory factor by inhibiting the recruitment of host leukocytes. Nature Medicine 2002 8 : 687 693.
37. Murdoch C, Finn A. Chemokine receptors and their role in inflammation and infectious diseases. Blood 2000 95 : 3032 3043.
38. de Haas CJ, Veldkamp KE, Peschel A et al. Chemotaxis inhibitory protein of Staphylococcus aureus, a bacterial antiinflammatory agent. Journal of Experimental Medicine 2004 199 : 687 695.
39. Haas PJ, de Haas CJ, Kleibeuker W et al. N-terminal residues of the chemotaxis inhibitory protein of Staphylococcus aureus are essential for blocking formylated peptide receptor but not C5a receptor. Journal of Immunology 2004 173 : 5704 5711.
40. Postma B, Kleibeuker W, Poppelier MJ et al. Residues 10-18 within the C5a receptor N terminus compose a binding domain for chemotaxis inhibitory protein of Staphylococcus aureus. Journal of Biological Chemistry 2005 280 : 2020 2027.
41. Postma B, Poppelier MJ, van Galen JC et al. Chemotaxis inhibitory protein of Staphylococcus aureus binds specifically to the C5a and formylated peptide receptor. Journal of Immunology 2004 172 : 6994 7001.
42. Prat C, Bestebroer J, de Haas CJ et al. A new staphylococcal anti-inflammatory protein that antagonizes the formyl peptide receptor-like 1. Journal of Immunology 2006 177 : 8017 8026.
43. van Wamel WJ, Rooijakkers SH, Ruyken M et al. The innate immune modulators staphylococcal complement inhibitor and chemotaxis inhibitory protein of Staphylococcus aureus are located on beta-hemolysin-converting bacteriophages. Journal of Bacteriology 2006 188 : 1310 1315.
44. Moore F. Complement. In : Pier GB, Lyczak JB, Wetzler LM, eds. Immunology, Infection, and Immunity. Washington, DC : ASM Press, 2004 : 85 109.
45. Fujita T. Evolution of the lectin-complement pathway and its role in innate immunity. Nature Reviews Immunology 2002 2 : 346 353.
46. Rooijakkers SH, Ruyken M, Roos A et al. Immune evasion by a staphylococcal complement inhibitor that acts on C3 convertases. Nature Immunology 2005 6 : 920 927.
47. Atkins KL, Burman JD, Chamberlain ES et al. S. aureus IgG-binding proteins SpA and Sbi: host specificity and mechanisms of immune complex formation. Molecular Immunology 2008 45 : 1600 1611.
48. Burman JD, Leung E, Atkins KL et al. Interaction of human complement with Sbi, a staphylococcal immunoglobulin-binding protein: indications of a novel mechanism of complement evasion by Staphylococcus aureus. Journal of Biological Chemistry 2008 283 : 17579 17593.
49. Bokarewa MI, Jin T, Tarkowski A. Staphylococcus aureus: Staphylokinase. International Journal of Biochemistry and Cell Biology 2006 38 : 504 509.
50. Rooijakkers SH, van Wamel WJ, Ruyken M et al. Anti-opsonic properties of staphylokinase. Microbes and Infection 2005 7 : 476 484.
51. Cunnion KM, Buescher ES, Hair PS. Serum complement factor I decreases Staphylococcus aureus phagocytosis. Journal of Laboratory and Clinical Medicine 2005 146 : 279 286.
52. Cunnion KM, Hair PS, Buescher ES. Cleavage of complement C3b to iC3b on the surface of Staphylococcus aureus is mediated by serum complement factor I. Infection and Immunity 2004 72 : 2858 2863.
53. Hair PS, Ward MD, Semmes OJ et al. Staphylococcus aureus clumping factor A binds to complement regulator factor I and increases factor I cleavage to C3b. Journal of Infectious Diseases 2008 198 : 125 133.
54. Lee LY, Hook M, Haviland D et al. Inhibition of complement activation by a secreted Staphylococcus aureus protein. Journal of Infectious Diseases 2004 190 : 571 579.
55. Lee LY, Liang X, Hook M et al. Identification and characterization of the C3 binding domain of the Staphylococcus aureus extracellular fibrinogen-binding protein (Efb). Journal of Biological Chemistry 2004 279 : 50710 50716.
56. Hammel M, Sfyroera G, Ricklin D et al. A structural basis for complement inhibition by Staphylococcus aureus. Nature Immunology 2007 8 : 430 437.
57. Jongerius I, Kohl J, Pandey MK et al. Staphylococcal complement evasion by various convertase-blocking molecules. Journal of Experimental Medicine 2007 204 : 2461 2471.
58. Uhlen M, Guss B, Nilsson B et al. Complete sequence of the staphylococcal gene encoding protein A. A gene evolved through multiple duplications. Journal of Biological Chemistry 1984 259 : 1695 1702.
59. Cedergren L, Andersson R, Jansson B et al. Mutational analysis of the interaction between staphylococcal protein A and human IgG1. Protein Engineering 1993 6 : 441 448.
60. Gemmell C, Tree R, Patel A et al. Susceptibility to opsonophagocytosis of protein A, alpha-haemolysin and beta-toxin deficient mutants of Staphylococcus aureus isolated by allele-replacement. In : Jeljaszewicz J, Cibrowski P (eds) The Staphylococci. Zentralblatt fur Bakteriologie, 1991 (Suppl. 21 273 277.
61. Palmqvist N, Foster T, Tarkowski A et al. Protein A is a virulence factor in Staphylococcus aureus arthritis and septic death. Microbial Pathogenesis 2002 33 : 239 249.
62. Patel AH, Nowlan P, Weavers ED et al. Virulence of protein A-deficient and alpha-toxin-deficient mutants of Staphylococcus aureus isolated by allele replacement. Infection and Immunity 1987 55 : 3103 3110.
63. Bischoff M, Dunman P, Kormanec J et al. Microarray-based analysis of the Staphylococcus aureus sigmaB regulon. Journal of Bacteriology 2004 186 : 4085 4099. (Pubitemid 38802556)
64. O'Brien L, Kerrigan SW, Kaw G et al. Multiple mechanisms for the activation of human platelet aggregation by Staphylococcus aureus: roles for the clumping factors ClfA and ClfB, the serine-aspartate repeat protein SdrE and protein A. Molecular Microbiology 2002 44 : 1033 1044.
65. Higgins J, Loughman A, van Kessel KP et al. Clumping factor A of Staphylococcus aureus inhibits phagocytosis by human polymorphonuclear leucocytes. FEMS Microbiology Letters 2006 258 : 290 296.
66. McDevitt D, Nanavaty T, House-Pompeo K et al. Characterization of the interaction between the Staphylococcus aureus clumping factor (ClfA) and fibrinogen. European Journal of Biochemistry 1997 247 : 416 424.
67. Josefsson E, Hartford O, O'Brien L et al. Protection against experimental Staphylococcus aureus arthritis by vaccination with clumping factor A, a novel virulence determinant. Journal of Infectious Diseases 2001 184 : 1572 1580.
68. Wann ER, Gurusiddappa S, Hook M. The fibronectin-binding MSCRAMM FnbpA of Staphylococcus aureus is a bifunctional protein that also binds to fibrinogen. Journal of Biological Chemistry 2000 275 : 13863 13871.
69. Keane FM, Loughman A, Valtulina V et al. Fibrinogen and elastin bind to the same region within the A domain of fibronectin binding protein A, an MSCRAMM of Staphylococcus aureus. Molecular Microbiology 2007 63 : 711 723.
70. Brinkmann V, Zychlinsky A. Beneficial suicide: why neutrophils die to make NETs. Nature Reviews Microbiology 2007 5 : 577 582.
71. Buchanan JT, Simpson AJ, Aziz RK et al. DNase expression allows the pathogen group A Streptococcus to escape killing in neutrophil extracellular traps. Current Biology 2006 16 : 396 400.
72. Beiter K, Wartha F, Albiger B et al. An endonuclease allows Streptococcus pneumoniae to escape from neutrophil extracellular traps. Current Biology 2006 16 : 401 407.
73. Roghmann M, Taylor KL, Gupte A et al. Epidemiology of capsular and surface polysaccharide in Staphylococcus aureus infections complicated by bacteraemia. Journal of Hospital Infection 2005 59 : 27 32.
74. O'Riordan K, Lee JC. Staphylococcus aureus capsular polysaccharides. Clinical Microbiology Reviews 2004 17 : 218 234.
75. Nilsson IM, Lee JC, Bremell T et al. The role of staphylococcal polysaccharide microcapsule expression in septicemia and septic arthritis. Infection and Immunity 1997 65 : 4216 4221.
76. Thakker M, Park JS, Carey V et al. Staphylococcus aureus serotype 5 capsular polysaccharide is antiphagocytic and enhances bacterial virulence in a murine bacteremia model. Infection and Immunity 1998 66 : 5183 5189.
77. Luong TT, Lee CY. Overproduction of type 8 capsular polysaccharide augments Staphylococcus aureus virulence. Infection and Immunity 2002 70 : 3389 3395.
78. Montoya M, Gouaux E. Beta-barrel membrane protein folding and structure viewed through the lens of alpha-hemolysin. Biochimica et Biophysica Acta 2003 1609 : 19 27.
79. Menestrina G, Dalla Serra M, Comai M et al. Ion channels and bacterial infection: the case of beta-barrel pore-forming protein toxins of Staphylococcus aureus. FEBS Letters 2003 552 : 54 60.
80. Peacock SJ, Moore CE, Justice A et al. Virulent combinations of adhesin and toxin genes in natural populations of Staphylococcus aureus. Infection and Immunity 2002 70 : 4987 4996.
81. Prevost G, Cribier B, Couppie P et al. Panton-Valentine leucocidin and gamma-hemolysin from Staphylococcus aureus ATCC 49775 are encoded by distinct genetic loci and have different biological activities. Infection and Immunity 1995 63 : 4121 4129.
82. Gillet Y, Issartel B, Vanhems P et al. Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet 2002 359 : 753 759.
83. Lina G, Piemont Y, Godail-Gamot F et al. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clinical Infectious Diseases 1999 29 : 1128 1132.
84. Brown EL, Dumitrescu O, Thomas D et al. The Panton-Valentine leukocidin vaccine protects mice against lung and skin infections caused by Staphylococcus aureus USA300. Clinical Microbiology and Infection 2009 15 : 156 164.
85. Voyich JM, Otto M, Mathema B et al. Is Panton-Valentine leukocidin the major virulence determinant in community-associated methicillin-resistant Staphylococcus aureus disease? Journal of Infectious Diseases 2006 194 : 1761 1770.
86. Narita S, Kaneko J, Chiba J et al. Phage conversion of Panton-Valentine leukocidin in Staphylococcus aureus: molecular analysis of a PVL-converting phage, phiSLT. Gene 2001 268 : 195 206.
87. Wang R, Braughton KR, Kretschmer D et al. Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA. Nature Medicine 2007 13 : 1510 1514.
88. Ramsland PA, Willoughby N, Trist HM et al. Structural basis for evasion of IgA immunity by Staphylococcus aureus revealed in the complex of SSL7 with Fc of human IgA1. Proceedings of the National Academy of Sciences of the USA 2007 104 : 15051 15056.
89. Wines BD, Willoughby N, Fraser JD et al. A competitive mechanism for staphylococcal toxin SSL7 inhibiting the leukocyte IgA receptor, Fc alphaRI, is revealed by SSL7 binding at the C alpha2/C alpha3 interface of IgA. Journal of Biological Chemistry 2006 281 : 1389 1393.
90. Kubica M, Guzik K, Koziel J et al. A potential new pathway for Staphylococcus aureus dissemination: the silent survival of S. aureus phagocytosed by human monocyte-derived macrophages. PLoS ONE 2008 3 : e1409.
91. Peschel A, Otto M, Jack RW et al. Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity to defensins, protegrins, and other antimicrobial peptides. Journal of Biological Chemistry 1999 274 : 8405 8410.
92. Peschel A, Jack RW, Otto M et al. Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with l-lysine. Journal of Experimental Medicine 2001 193 : 1067 1076.
93. Staubitz P, Neumann H, Schneider T et al. MprF-mediated biosynthesis of lysylphosphatidylglycerol, an important determinant in staphylococcal defensin resistance. FEMS Microbiology Letters 2004 231 : 67 71.
94. Kristian SA, Durr M, Van Strijp JA et al. MprF-mediated lysinylation of phospholipids in Staphylococcus aureus leads to protection against oxygen-independent neutrophil killing. Infection and Immunity 2003 71 : 546 549.
95. Kristian SA, Lauth X, Nizet V et al. Alanylation of teichoic acids protects Staphylococcus aureus against Toll-like receptor 2-dependent host defense in a mouse tissue cage infection model. Journal of Infectious Diseases 2003 188 : 414 423.
96. Collins LV, Kristian SA, Weidenmaier C et al. Staphylococcus aureus strains lacking D-alanine modifications of teichoic acids are highly susceptible to human neutrophil killing and are virulence attenuated in mice. Journal of Infectious Diseases 2002 186 : 214 219.
97. Li M, Lai Y, Villaruz AE et al. Gram-positive three-component antimicrobial peptide-sensing system. Proceedings of the National Academy of Sciences of the USA 2007 104 : 9469 9474. (Pubitemid 47185803)
98. Lai Y, Villaruz AE, Li M et al. The human anionic antimicrobial peptide dermcidin induces proteolytic defence mechanisms in staphylococci. Molecular Microbiology 2007 63 : 497 506.
99. Bokarewa M, Tarkowski A. Human alpha-defensins neutralize fibrinolytic activity exerted by staphylokinase. Thrombosis and Haemostases 2004 91 : 991 999.
100. Jin T, Bokarewa M, Foster T et al. Staphylococcus aureus resists human defensins by production of staphylokinase, a novel bacterial evasion mechanism. Journal of Immunology 2004 172 : 1169 1176.
101. Braff MH, Jones AL, Skerrett SJ et al. Staphylococcus aureus exploits cathelicidin antimicrobial peptides produced during early pneumonia to promote staphylokinase-dependent fibrinolysis. Journal of Infectious Diseases 2007 195 : 1365 1372.
102. Sieprawska-Lupa M, Mydel P, Krawczyk K et al. Degradation of human antimicrobial peptide LL-37 by Staphylococcus aureus-derived proteinases. Antimicrobial Agents and Chemotherapy 2004 48 : 4673 4679.
103. Keshav S, Chung P, Milon G et al. Lysozyme is an inducible marker of macrophage activation in murine tissues as demonstrated by in situ hybridization. Journal of Experimental Medicine 1991 174 : 1049 1058.
104. Bera A, Herbert S, Jakob A et al. Why are pathogenic staphylococci so lysozyme resistant? The peptidoglycan O-acetyltransferase OatA is the major determinant for lysozyme resistance of Staphylococcus aureus. Molecular Microbiology 2005 55 : 778 787.
105. Watanabe I, Ichiki M, Shiratsuchi A et al. TLR2-mediated survival of Staphylococcus aureus in macrophages: a novel bacterial strategy against host innate immunity. Journal of Immunology 2007 178 : 4917 4925.
106. Liu GY, Essex A, Buchanan JT et al. Staphylococcus aureus golden pigment impairs neutrophil killing and promotes virulence through its antioxidant activity. Journal of Experimental Medicine 2005 202 : 209 215.
107. Karavolos MH, Horsburgh MJ, Ingham E et al. Role and regulation of the superoxide dismutases of Staphylococcus aureus. Microbiology 2003 149 : 2749 2758.
108. Horsburgh MJ, Wharton SJ, Cox AG et al. MntR modulates expression of the PerR regulon and superoxide resistance in Staphylococcus aureus through control of manganese uptake. Molecular Microbiology 2002 44 : 1269 1286.
109. Singh VK, Moskovitz J. Multiple methionine sulfoxide reductase genes in Staphylococcus aureus: expression of activity and roles in tolerance of oxidative stress. Microbiology 2003 149 : 2739 2747.
110. Mei JM, Nourbakhsh F, Ford CW et al. Identification of Staphylococcus aureus virulence genes in a murine model of bacteraemia using signature-tagged mutagenesis. Molecular Microbiology 1997 26 : 399 407.
111. Richardson AR, Libby SJ, Fang FC. A nitric oxide-inducible lactate dehydrogenase enables Staphylococcus aureus to resist innate immunity. Science 2008 319 : 1672 1676.
112. Palazzolo-Ballance AM, Reniere ML, Braughton KR et al. Neutrophil microbicides induce a pathogen survival response in community-associated methicillin-resistant Staphylococcus aureus. Journal of Immunology 2008 180 : 500 509.
113. Schwarz-Linek U, Werner JM, Pickford AR et al. Pathogenic bacteria attach to human fibronectin through a tandem beta-zipper. Nature 2003 423 : 177 181.
114. Peacock SJ, Foster TJ, Cameron BJ et al. Bacterial fibronectin-binding proteins and endothelial cell surface fibronectin mediate adherence of Staphylococcus aureus to resting human endothelial cells. Microbiology 1999 145 : 3477 3486.
115. Proctor RA, von Eiff C, Kahl BC et al. Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infections. Nature Reviews Microbiology 2006 4 : 295 305.
116. Mack D. Molecular mechanisms of Staphylococcus epidermidis biofilm formation. Journal of Hospital Infection 1999 43 (Suppl S113 25.
117. Mack D, Becker P, Chatterjee I et al. Mechanisms of biofilm formation in Staphylococcus epidermidis and Staphylococcus aureus: functional molecules, regulatory circuits, and adaptive responses. International Journal of Medical Microbiology 2004 294 : 203 212.
118. Heilmann C, Hussain M, Peters G et al. Evidence for autolysin-mediated primary attachment of Staphylococcus epidermidis to a polystyrene surface. Molecular Microbiology 1997 24 : 1013 1024.
119. Hartford O, O'Brien L, Schofield K et al. The Fbe (SdrG) protein of Staphylococcus epidermidis HB promotes bacterial adherence to fibrinogen. Microbiology 2001 147 : 2545 2552. (Pubitemid 32899250)
120. Nilsson M, Frykberg L, Flock JI et al. A fibrinogen-binding protein of Staphylococcus epidermidis. Infection and Immunity 1998 66 : 2666 2673.
121. Mack D, Fischer W, Krokotsch A et al. The intercellular adhesin involved in biofilm accumulation of Staphylococcus epidermidis is a linear beta-1,6-linked glucosaminoglycan: purification and structural analysis. Journal of Bacteriology 1996 178 : 175 183.
122. Vuong C, Voyich JM, Fischer ER et al. Polysaccharide intercellular adhesin (PIA) protects Staphylococcus epidermidis against major components of the human innate immune system. Cellular Microbiology 2004 6 : 269 275.
123. Hennig S, Nyunt Wai S, Ziebuhr W. Spontaneous switch to PIA-independent biofilm formation in an ica-positive Staphylococcus epidermidis isolate. International Journal of Medical Microbiology 2007 297 : 117 122.
124. Rohde H, Burdelski C, Bartscht K et al. Induction of Staphylococcus epidermidis biofilm formation via proteolytic processing of the accumulation-associated protein by staphylococcal and host proteases. Molecular Microbiology 2005 55 : 1883 1895.
125. O'Neill E, Pozzi C, Houston P et al. A novel Staphylococcus aureus biofilm phenotype mediated by the fibronectin-binding proteins, FnBPA and FnBPB. Journal of Bacteriology 2008 190 : 3835 3850.
126. Kocianova S, Vuong C, Yao Y et al. Key role of poly-gamma-DL-glutamic acid in immune evasion and virulence of Staphylococcus epidermidis. Journal of Clinical Investigation 2005 115 : 688 694.
127. Little SF, Ivins BE. Molecular pathogenesis of Bacillus anthracis infection. Microbes and Infection 1999 1 : 131 139.
128. Goodyear CS, Silverman GJ. Staphylococcal toxin induced preferential and prolonged in vivo deletion of innate-like B lymphocytes. Proceedings of the National Academy of Sciences of the USA 2004 101 : 11392 11397.
129. Silverman GJ, Cary S, Graille M et al. A B-cell superantigen that targets B-1 lymphocytes. Current Topics in Microbiology and Immunology 2000 252 : 251 263.
130. Silverman GJ, Goodyear CS. A model B-cell superantigen and the immunobiology of B lymphocytes. Clinical Immunology 2002 102 : 117 134.
131. Gomez MI, O'Seaghdha M, Magargee M et al. Staphylococcus aureus protein A activates TNFR1 signaling through conserved IgG binding domains. Journal of Biological Chemistry 2006 281 : 20190 20196.
132. O'Seaghdha M, van Schooten CJ, Kerrigan SW et al. Staphylococcus aureus protein A binding to von Willebrand factor A1 domain is mediated by conserved IgG binding regions. FEBS Journal 2006 273 : 4831 4841.
133. Alber G, Hammer DK, Fleischer B. Relationship between enterotoxic- and T lymphocyte-stimulating activity of staphylococcal enterotoxin B. Journal of Immunology 1990 144 : 4501 4506.
134. Chesney PJ, Bergdoll MS, Davis JP et al. The disease spectrum, epidemiology, and etiology of toxic-shock syndrome. Annual Review of Microbiology 1984 38 : 315 338.
135. Bohach GA, Foster TJ. Staphylococcus aureus exotoxins. In : Fischetti V R, Novick JJ, Ferretti DA et al., eds. Gram Positive Pathogens. Washington DC, USA : American Society for Microbiology Press, 1999 : 367 378.
136. Llewelyn M, Cohen J. Superantigens: microbial agents that corrupt immunity. Lancet Infectious Diseases 2002 2 : 156 162.
137. Proft T, Fraser JD. Bacterial superantigens. Clinical and Experimental Immunology 2003 133 : 299 306.
138. Choi Y, Lafferty JA, Clements JR et al. Selective expansion of T cells expressing V beta 2 in toxic shock syndrome. Journal of Experimental Medicine 1990 172 : 981 984.
139. Hudson KR, Robinson H, Fraser JD. Two adjacent residues in staphylococcal enterotoxins A and E determine T cell receptor V beta specificity. Journal of Experimental Medicine 1993 177 : 175 184.
140. Lussow AR, MacDonald HR. Differential effects of superantigen-induced "anergy" on priming and effector stages of a T cell-dependent antibody response. European Journal of Immunology 1994 24 : 445 449.
141. Jonsson K, McDevitt D, McGavin MH et al. Staphylococcus aureus expresses a major histocompatibility complex class II analog. Journal of Biological Chemistry 1995 270 : 21457 21460.
142. Lee LY, Miyamoto YJ, McIntyre BW et al. The Staphylococcus aureus Map protein is an immunomodulator that interferes with T cell-mediated responses. Journal of Clinical Investigation 2002 110 : 1461 1471.
143. Haggar A, Shannon O, Norrby-Teglund A et al. Dual effects of extracellular adherence protein from Staphylococcus aureus on peripheral blood mononuclear cells. Journal of Infectious Diseases 2005 192 : 210 217.
144. Stauff DL, Bagaley D, Torres VJ et al. Staphylococcus aureus HrtA is an ATPase required for protection against heme toxicity and prevention of a transcriptional heme stress response. Journal of Bacteriology 2008 190 : 3588 3596.
145. Moreillon P, Que YA. Infective endocarditis. Lancet 2004 363 : 139 149.
146. Moreillon P, Que YA, Bayer AS. Pathogenesis of streptococcal and staphylococcal endocarditis. Infectious Disease Clinics of North America 2002 16 : 297 318.
147. Fitzgerald JR, Loughman A, Keane F et al. Fibronectin-binding proteins of Staphylococcus aureus mediate activation of human platelets via fibrinogen and fibronectin bridges to integrin GPIIb/IIIa and IgG binding to the FcgammaRIIa receptor. Molecular Microbiology 2006 59 : 212 230.
148. Loughman A, Fitzgerald JR, Brennan MP et al. Roles for fibrinogen, immunoglobulin and complement in platelet activation promoted by Staphylococcus aureus clumping factor A. Molecular Microbiology 2005 57 : 804 818.
149. Moodley A, Stegger M, Ben Zakour NL et al. Tandem repeat sequence analysis of staphylococcal protein A (spa) gene in methicillin-resistant Staphylococcus pseudintermedius. Veterinary Microbiology 2009 135 : 320 326.